A new method for radiochemical separation of arsenic from irradiated germanium oxide

Al-Kourashi, 1978, An isotope generator for 72As, Int. J. Appl. Radiat. Isot., 29, 607, 10.1016/0020-708X(78)90093-5 Basile, 1984, Excitation functions and production of arsenic radioisotopes for environmental toxicology and biomedical purposes, Int. J. Appl. Radiat. Isot., 32, 403, 10.1016/S0020-708X(81)81007-1 Beard, 1960 Byrne, A.R., 1984. Simple production of 77As from reactor irradiated germanium. International Conference on Nuclear Radiochemistry, p. 239. Chen, 1996, In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins, Blood, 88, 1052, 10.1182/blood.V88.3.1052.1052 Chen, 1997, Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells, Blood, 89, 3345 Dmitriev, 1986 Evans, 2004, Effect of arsenic on benzo[a]pyrene DNA adduct levels in mouse skin and lung, Carcinogenesis, 25, 493, 10.1093/carcin/bgg199 Halpern, 1964, The chemical forms of radioarsenic activated in β− decay of 77GeCl4 and in the 75AsCl3 (n,γ) reaction in benzene, Radiochimica Acta, 3, 40, 10.1524/ract.1964.3.12.40 Horiguchi, 1983, Excitation functions of Ge(p,xnpy) reactions and production of 68Ge, Int. J. Appl. Radiat. Isot., 34, 1531, 10.1016/0020-708X(83)90288-0 Jennewein, 2003, Macroscopic synthesis of arsenoorganic precursors and first no-carrier-added radioarsenic labelling, J. Lab. Comp. Radiopharm., 46, 42 Jennewein, 2003, Synthesis of 1,3-dimercaptopropyl arsenic-BOC-cysteine-O-BZL and diphenyl arsenic-BOC-cysteine-O-Bzl and first radioarsenic labelling, J. Lab. Comp. Radiopharm., 46, 283 Jennewein, 2004, Molecular imaging of the vascular targeting antibody vatuximab® in rat prostate cancer, Eur. J. Nuc. Med. Mol. Im., 31, 259 Jennewein, 2004, A no-carrier-added 72Se/72As radionuclide generator based on distillation, Radiochimica Acta, 92, 245, 10.1524/ract.92.4.245.35611 Jennewein, M., Qaim, S.M., Kulkarni, P.V., Mason, R.P., Hermanne, A., Roesch, F., 2005. A no-carrier-added 72Se/72As radionuclide generator based on solid phase extraction. Radiochimica Acta, Submitted for publication. Leicester, 1966, The detection of cerebral lesions by the newer forms of encephalography: positron scanning and echoencephalography, Med. J. Aust., 2, 680, 10.5694/j.1326-5377.1966.tb97441.x Maki, 1974, The separation of arsenic-77 in a carrier-free state from the parent nuclide germanium-77 by a thin-layer chromatographic method, J. Radioanal. Chem., 22, 5, 10.1007/BF02518087 Mausner, 2004, Production of 73As by irradiation of Ge target, J. Nucl. Med., 45, 471 Mealey, 1963, Radioisotopic localization in subdural hematomas. An experimental study with arsenic-74 and radioiodinated human serum albumin in dogs, J. Neurosurg., 20, 770, 10.3171/jns.1963.20.9.0770 Miller, 2002, Mechanisms of action of arsenic trioxide, Cancer Res., 62, 3893 Mirzadeh, 1986, Studies of the chemical behavior of carrier-free 68Ge: III. adsorptive properties, Radiochimica Acta, 39, 189, 10.1524/ract.1986.39.2.73 Mirzadeh, 1996, Radiochemistry of germanium, J. Radioanal. Nuc. Chem., 202, 7, 10.1007/BF02037941 Mirzadeh, 1981, Studies of the chemical behavior of carrier-free 68Ge: I. purification by distillation from acidic chloride solutions, Radiochimica Acta, 28, 47, 10.1524/ract.1981.28.1.47 Mukhopadhyay, 2002, Separation of no-carrier-added As and Se produced in 16O irradiated cobalt target, J. Radioanal. Nuc. Chem., 251, 159, 10.1023/A:1015027218470 National Nuclear Data Center, Brookhaven National Laboratory. 2004, http://www.nndc.bnl.gov/nudat2/index.jsp. Phillips, D.R., 1994. Chemistry and concept for an automated 72Se/72As generator. Patent No. 5,371,372, United States. Phillips, D.R., Hamilton, V.T., Nix, D.A., Taylor, W.A., Jamriska, D.J., Staroski, R.C., Lopez, R.A., Emran, A.M., 1991. Chemistry and concept for an automated 72Se/72As generator. New Trends Radiopharm. Synth., QA Regul. Control 173–181. Phillips, 1992, Generator-produced arsenic-72 in positron emission tomography, Radioact. Radiochem., 3, 53 Ravandi, 2004, Arsenic trioxide: expanding roles for an ancient drug?, Leukemia, 18, 1457, 10.1038/sj.leu.2403419 Rösch, 2003, Radionuclide generators, 81 Rösch, F., Novgorodov, A.F., Brockmann, J., 2002. Offenlegungsschrift DE 100 28 056 A 1. In Deutsches Patent- und Markenamt, Deutschland. Schindewolf, 1958, Preparation of carrier-free vanadium, scandium and arsenic activities from cyclotron targets by ion exchange, Anal. Chem., 30, 906, 10.1021/ac60137a011 Shen, 1997, Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients, Blood, 89, 3354, 10.1182/blood.V89.9.3354 Shriver, 1997 Smith, 1973 Sweet, 1955, Localization of intracranial lesions by scanning with positron-emitting arsenic, J. Am. Med. Assoc., 157, 1183, 10.1001/jama.1955.02950310009002 The U.S. Geological Survey Workshop on arsenic in the environment, available at wwwbrr.cr.usgs.gov/Arsenic/. 2004. Wang, 2001, Arsenic compounds as anticancer agents, Cancer Chemother. Pharmacol., 48, S72, 10.1007/s002800100309 Ward, 1970, Radiochemical procedure for arsenic and germanium, Radiochimica Acta, 14, 70, 10.1524/ract.1970.14.2.70 Wilcke, 1965, The diagnosis of brain tumors using isotopes, Nervenarzt, 36, 508 Wilcke, 1965, Scintigraphy of brain tumors, Radiologe, 5, 393 Wilcke, 1965, Positrocephalography. Results in 1400 cases. Comparative study with angiography, pneumoencephalography and electroencephalography, Arq. Neuropsiquiatr., 23, 261, 10.1590/S0004-282X1965000400003 Zhu, 1997, Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia, Proc. Natl. Acad. Sci. USA, 94, 3978, 10.1073/pnas.94.8.3978 Zhu, 2001, Pathways of retinoic acid- or arsenic trioxide-induced PML/RARalpha catabolism, role of oncogene degradation in disease remission, Oncogene, 20, 7257, 10.1038/sj.onc.1204852 Zhu, 2002, How acute promyelocytic leukaemia revived arsenic, Nat. Rev. Cancer, 2, 705, 10.1038/nrc887 Zhu, 2003, Arsenic trioxide induces apoptosis in leukemia/lymphoma cell lines via the CD95/CD95L system, Oncol. Rep., 0, 705 Zingaro, 1994, Arsenic: inorganic and organoarsenic chemistry, 192